Thank you, and welcome to everybody joining us today. Alongside this, we're continuing to make excellent progress in R&D, strengthening our late-stage portfolio and already securing four FDA approvals ...
In all, we will be distributing total dividends of approximately $0.47 per share for financial year 2025, up 38% from financial year 2024, which represents a yield of approximately 4.3% based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results